Related references
Note: Only part of the references are listed.International Society of Urological Pathology Expert Opinion on Grading of Urothelial Carcinoma
Theo van der Kwast et al.
EUROPEAN UROLOGY FOCUS (2022)
European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ)
Marko Babjuk et al.
EUROPEAN UROLOGY (2022)
All High-Grade Ta Tumors Should be Classified as High Risk: Bacillus Calmette-Guerin Response in High-Grade Ta Tumors
Kelly K. Bree et al.
JOURNAL OF UROLOGY (2022)
Primary Ta high grade bladder tumors: Determination of the risk of progression
Fahad Quhal et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2021)
European Association of Urology (EAU) Prognostic Factor Risk Groups for Non-muscle-invasive Bladder Cancer (NMIBC) Incorporating the WHO 2004/2016 and WHO 1973 Classification Systems for Grade: An Update from the EAU NMIBC Guidelines Panel
Richard J. Sylvester et al.
EUROPEAN UROLOGY (2021)
Prognostic Value of the WHO1973 and WHO2004/2016 Classification Systems for Grade in Primary Ta/T1 Non-muscle-invasive Bladder Cancer: A Multicenter European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel Study
Bas W. G. van Rhijn et al.
EUROPEAN UROLOGY ONCOLOGY (2021)
The prognostic value of routine second transurethral resection in patients with newly diagnosed stage pT1 non-muscle-invasive bladder cancer: results from randomized 10-year extension trial
Askin Eroglu et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2020)
Risk Stratification Tools and Prognostic Models in Non-muscle-invasive Bladder Cancer: A Critical Assessment from the European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel
Viktor Soukup et al.
EUROPEAN UROLOGY FOCUS (2020)
Repeat Transurethral Resection in Non-muscle-invasive Bladder Cancer: A Systematic Review
Marcus G. K. Cumberbatch et al.
EUROPEAN UROLOGY (2018)
The impact of re-transurethral resection on clinical outcomes in a large multicentre cohort of patients with T1 high-grade/Grade 3 bladder cancer treated with bacille Calmette-Guerin
Paolo Gontero et al.
BJU INTERNATIONAL (2016)
Analysis of results of recurrence and progression rates of high-grade Ta bladder cancer and comparison with results of high-grade T1
Muhammet Fatih Kilinc et al.
UROLOGIA JOURNAL (2014)
High-grade non-muscle-invasive bladder cancer: Is re-resection necessary in all patients before intravesical bacillus Calmette-Guerin treatment?
Sten Holmang
SCANDINAVIAN JOURNAL OF UROLOGY (2013)
Best practice in the treatment of nonmuscle invasive bladder cancer
Anastasios Anastasiadis et al.
THERAPEUTIC ADVANCES IN UROLOGY (2012)
Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: A combined analysis of 2596 patients from seven EORTC trials
RJ Sylvester et al.
EUROPEAN UROLOGY (2006)
High-grade Ta urothelial carcinoma and carcinoma in situ of the bladder
RJ Sylvester et al.
UROLOGY (2005)
Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: A meta-analysis of the published results of randomized clinical trials
RJ Sylvester et al.
JOURNAL OF UROLOGY (2002)
The role and impact of pathology review on stage and grade assessment of stages Ta and T1 bladder tumors: A combined analysis of 5 European organization for research and treatment of cancer trials
A Van Der Meijden et al.
JOURNAL OF UROLOGY (2000)
Recurrence, progression and success in stage Ta grade 3 bladder tumors treated with low dose bacillus Calmette-Guerin instillations
T Lebret et al.
JOURNAL OF UROLOGY (2000)
Tumor progression and survival of patients with high grade, noninvasive papillary (TaG3) bladder tumors: 15-year outcome
HW Herr
JOURNAL OF UROLOGY (2000)
Share Paper
